Menopause and Alzheimer's disease susceptibility: Exploring the potential mechanisms

Brain Res. 2024 Dec 1:1844:149170. doi: 10.1016/j.brainres.2024.149170. Epub 2024 Aug 18.

Abstract

Alzheimer's Disease (AD), responsible for 62% of all dementia cases, is a progressive neurodegenerative condition that leads to cognitive dysfunction. The prevalence of AD is consistently higher in women suggesting they are disproportionately affected by this disease. Despite this, our understanding of this female AD vulnerability remains limited. Menopause has been identified as a potential contributing factor to AD in women, with earlier menopause onset associated with greater AD risk. However, the underlying mechanisms responsible for this increased risk are not fully understood. This review examines the potential role of menopause in the development of Alzheimer's Disease providing a mechanistic overview of the available literature from hormones to pathology. While literature is now emerging that indicates a role of hormonal shifts, gut dysbiosis, lipid dysregulation and inflammation, more research is needed to fully elucidate the mechanisms involved.

Keywords: APOE; Ageing; Alzheimer’s Disease; Estrogen; Menopause; Sex Differences.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / metabolism
  • Animals
  • Disease Susceptibility
  • Dysbiosis
  • Female
  • Humans
  • Menopause* / physiology